Kenneth F. Binmoeller

Kenneth F. Binmoeller

Biography

Dr Kenneth F. Binmoeller

Medical Director
Interventional Endoscopy Service
California Pacific Medical Center
San Francisco, USA


Kenneth F. Binmoeller, MD, is recognized nationally and internationally as an authority and leader in advanced endoscopic procedures and endosonography. He has been performing complex interventional endoscopic procedures since the late 1980’s and has authored more than 200 publications and several books. Dr. Binmoeller is a Fellow of the American College of Gastroenterology (FACG) and the American Society for Gastrointestinal Endoscopy (FASGE). In 2013 the ASGE honored Dr Binmoeller with the prestigious Master Endoscopist of the Year Award.

Dr Binmoeller is the founder and Director of Interventional Endoscopy Services (IES) at California Pacific Medical Center in San Francisco. Founded in 2001, this was the first center of its kind dedicated to the practice and advancement of therapeutic endoscopy. IES has become the premier referral center in Northern California and greater region for endoscopic alternatives to surgery. Patients from across the U.S. and abroad seek endoscopic care at IES.

Dr Binmoeller lists three career-long passions: Endoscopy, Innovation, and Teaching. Endoscopy is the overriding passion that fuels the rest. He is a “universal endoscopist” with expertise in all aspects of interventional endoscopy. His daily practice inspired innovation to improve outcomes for his patients and enable new procedures. He holds over 50 patents for novel endoscopic technologies.

Several of Dr Binmoeller’s inventions have developed to successful commercial products that benefit patients around the world. His first patent, filed in 1998, was for an automated device for endosonography-guided tissue sampling. The patent was assigned to the Olympus Medical Corporation for development and global commercialization of the NA-11J-KB Powershot™ needle. Dr Binmoeller founded his first company, Xlumena Inc, in 2004 around a portfolio of inventions for EUS-guided translumenal therapy. Xlumena was acquired in April 2015 by Boston Scientific, which has enabled the global commercialization of the AXIOS lumen-apposing stent™*. Dr Binmoeller’s second company, EndoSphere Inc, was created around a group of patents that enable physiologic treatment of obesity and metabolic diseases. EndoSphere’s Satisphere™ duodenal implant is currently in clinical trials. Dr Binmoeller has recently launched two companies for innovative technologies for the treatment of GERD and tissue remodeling.

Because innovation can only disseminate to benefit patients through teaching, Dr. Binmoeller considers teaching the most rewarding of his passions. He has trained and mentored endoscopists from all corners of the world. In 2002 he started a postgraduate International Scholar’s Program in Advanced Endoscopy at California Pacific Medical Center and has trained nearly 2 dozen international fellowship scholars.